Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with ALXN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.72%||PowerShares Dynamic Biotech &Genome (PBE)||+6.41 (12.51%)|
|4.26%||Market Vectors Biotech ETF (BBH)||+16.30 (13.72%)|
|3.18%||iShares Nasdaq Biotechnology Index Fund (IBB)||+56.94 (18.17%)|
|2.86%||First Trust Amex Biotech Index Fund (FBT)||+16.57 (15.59%)|
|2.49%||PowerShares DWA Momentum Portfolio (PDP)||+2.01 (4.87%)|
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Our marketed product Soliris is the first and only therapeutic approved for patients with either of two severe and ultra-rare disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening and ultra-rare genetic blood disorder, and atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. ... More ...
Where does ALXN fit in the risk graph?
|Annual EPS Est:||$4.64|
|Quarterly EPS Est:||1.3|